M2 PRESSWIRE-April 26, 2017-Sarcoidosis – Pipeline Insights, 2017
(C)1994-2017 M2 COMMUNICATIONS
RDATE:26042017
Dublin – Research and Markets has announced the addition of the Sarcoidosis – Pipeline Insights, 2017 drug pipelines to their offering.
Sarcoidosis – Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Sarcoidosis. This report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Sarcoidosis. This report also assesses the Sarcoidosis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
Please Note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.
Scope:
– The report provides competitivepipeline landscape of Sarcoidosis
– The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
– Coverage of the Sarcoidosis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
– The report reviews key players involved in the therapeutics development for Sarcoidosis and also provide company profiling
– The report also gives the information of dormant and discontinued pipeline projects
– Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
– Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Delivery Time: 2 Working Days.
Key Topics Covered:
Sarcoidosis Overview
Sarcoidosis Pipeline Therapeutics
Sarcoidosis Therapeutics under Development by Companies
Sarcoidosis Filed and Phase III Products
Comparative Analysis
Sarcoidosis Phase II Products
Comparative Analysis
Sarcoidosis Phase I and IND Filed Products
Comparative Analysis
Sarcoidosis Discovery and Pre-Clinical Stage Products
Comparative Analysis
Drug Candidate Profiles
Sarcoidosis – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Sarcoidosis – Discontinued Products
Sarcoidosis – Dormant Products
Companies Involved in Therapeutics Development for Sarcoidosis
Appendix
Methodology
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Sarcoidosis, 2017
Number of Products under Development by Companies
Comparative Analysis by Filed and Phase III Products, 2017
Comparative Analysis Phase II Products, 2017
Comparative Analysis Phase I and IND Filed Products, 2017
Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
Drug Candidates Profiles
Sarcoidosis Assessment by Monotherapy Products
Sarcoidosis Assessment by Combination Products
Sarcoidosis Assessment by Route of Administration
Sarcoidosis Assessment by Stage and Route of Administration
Sarcoidosis Assessment by Molecule Type
Sarcoidosis Assessment by Stage and Molecule Type
Sarcoidosis Therapeutics – Discontinued Products
Sarcoidosis Therapeutics – Dormant Products
Products under Development by Companies, 2017
List of Figures
Number of Products under Development for Sarcoidosis, 2017
Filed and Phase III Products, 2017
Phase II Products, 2017
Phase I and IND Filed Products, 2017
Discovery and Pre-Clinical Stage Products, 2017
Sarcoidosis Assessment by Monotherapy Products
Sarcoidosis Assessment by Combination Products
Sarcoidosis Assessment by Route of Administration
Sarcoidosis Assessment by Stage and Route of Administration
Sarcoidosis Assessment by Molecule Type
Sarcoidosis Assessment by Stage and Molecule Type
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/9rxbbk/sarcoidosis
About Research and Markets
Research and Markets is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.